These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12402178)

  • 1. Combination of estrogen replacement and exercise protects against HDL oxidation in post-menopausal women.
    Lawler JM; Hu Z; Green JS; Crouse SF; Grandjean PW; Bounds RG
    Int J Sports Med; 2002 Oct; 23(7):477-83. PubMed ID: 12402178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
    Imperato F; Marziani R; Perniola G; Ebano V; Fruscella M; Mossa B
    Minerva Ginecol; 2003 Feb; 55(1):87-93. PubMed ID: 12598849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of estrogen-only therapy on LDL oxidation in women with hysterectomy: does paraoxonase genotype play a role?
    Akçay YD; Sagin FG; Sendağ F; Oztekin K; Sozmen EY
    Maturitas; 2006 Feb; 53(3):325-32. PubMed ID: 16023312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of antioxidant adjuvant treatment with hormone replacement therapy against cardiovascular diseases in ovariectomized rats.
    Shehata M; Kamel MA
    Endocr Regul; 2008 Jun; 42(2-3):69-75. PubMed ID: 18624609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormone replacement therapy and cardiovascular risk].
    Maffei S; De Caterina R
    G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between physical activity and lipoprotein subclasses in postmenopausal women: the influence of hormone therapy.
    Pettee KK; Kriska AM; Johnson BD; Conroy MB; Mackey RH; Orchard TJ; Kuller LH
    Menopause; 2007; 14(1):115-22. PubMed ID: 17023874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of postmenopausal hormone therapy with markers of hemostasis and inflammation and lipid profiles in diabetic and nondiabetic american Indian women: the strong heart study.
    Zhang Y; Howard BV; Cowan LD; Welty TK; Schaefer CF; Wild RA; Yeh J; Lee ET
    J Womens Health (Larchmt); 2004 Mar; 13(2):155-63. PubMed ID: 15072729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial work environment and lifestyle as related to lipid profiles in perimenopausal women.
    Evolahti A; Hultcrantz M; Collins A
    Climacteric; 2009 Apr; 12(2):131-45. PubMed ID: 19085562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: a randomized, double-blind, crossover study.
    Koh KK; Han SH; Shin MS; Ahn JY; Lee Y; Shin EK
    Eur Heart J; 2005 Jul; 26(14):1362-8. PubMed ID: 15872028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the antioxidant effect of estriol and estradiol on low density lipoproteins in post-menopausal women].
    Arteaga E; Villaseca P; Rojas A; Arteaga A; Bianchi M
    Rev Med Chil; 1998 May; 126(5):481-7. PubMed ID: 9731428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
    Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
    Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of estrogens and progestogens on the lipid profile in postmenopausal hypogonadism].
    García L; Hernández I; Cervera Aguilar R; Ayala AR
    Ginecol Obstet Mex; 2001 Sep; 69():351-4. PubMed ID: 11816532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hormone therapy on lipid profile in menopausal women.
    Saranyaratana W; Sakondhavat C; Silaruks S; Soontrapa S; Kaewrudee S
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S37-41. PubMed ID: 17726808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase activities in hispanic and anglo postmenopausal women: associations with total and regional body fat.
    Greaves KA; Going SB; Fernandez ML; Milliken LA; Lohman TG; Bassford T; McNamara DJ
    Metabolism; 2003 Mar; 52(3):282-9. PubMed ID: 12647264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease risk factors in habitual exercisers, lean sedentary men and abdominally obese sedentary men.
    O'Donovan G; Owen A; Kearney EM; Jones DW; Nevill AM; Woolf-May K; Bird SR
    Int J Obes (Lond); 2005 Sep; 29(9):1063-9. PubMed ID: 15925958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The benefits of oestrogens on postprandial lipid metabolism are lost in post-menopausal women with Type 2 diabetes.
    Masding MG; Stears AJ; Burdge GC; Wootton SA; Sandeman DD
    Diabet Med; 2006 Jul; 23(7):768-74. PubMed ID: 16842482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
    McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
    Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.